- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03021369
Comparison of Two Different Pleural Drainage Systems
Vergleich Zweier Thoraxdrainage-Systeme in Der Herzchirurgie
The digital pleural drainage system Topaz+ by Medela is compared to the analogue system Atrium OCEAN by Maquet in patients undergoing cardiac surgery.
The study is prospectively randomized with an all-comer setup. The patients are randomly selected for one of the systems. The surgery is performed in the standard fashion and chest tubes are placed routinely by the surgeon depending on the type of surgery. A retrosternal 32 French drain is placed in every patient and pericardial and/or pleural drains are optional.
The postoperative course does not vary from the clinical standard and the chest tubes are removed according to institutional standard. The clinical data about fluid amount, time of removal, air leaks, tamponade are routinely collected in a digital patient documentation system.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bad Nauheim, Germany, 61231
- Kerckhoff Klinik
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- adult patients undergoing cardiac surgery
- capability to give informed consent
Exclusion Criteria:
- no specific exclusion criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Pleural drainage system Medela
These patients receive the digital Medela system
|
Pleural drainage system is connected to the chest tubes after surgery.
|
|
Active Comparator: Pleural drainage system Ocean
These patients receive the analogue Maquet system
|
Pleural drainage system is connected to the chest tubes after surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Detection of air leak due to lung leakage or injury during surgery by the pleural drainage system.
Time Frame: Occurrence of air leak is until the drain is removed (usually postoperative day 2 or 3)
|
The Thopaz+ system displays the amount of air leak on the screen in ml/min and the Ocean system is a 'wet seal' system, where bubbles in the box might indicate an air leak.
If air leak is detected, the train cannot be removed and has to stay until no more air leak is detected.
If air leak is unclear, chest x-rays with clamped drains are performed.
If an pneumothorax is visible in the x-ray, the drains have to stay, otherwise they can be removed safely.
The digital air leak detection and quantification by the Thopaz+ system might help in clearly detecting the air leaks.
|
Occurrence of air leak is until the drain is removed (usually postoperative day 2 or 3)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Time of chest drain removal
Time Frame: Number of days until the chest drains are removed (usually postoperative day 2 or 3, depending on air leak and amount of fluid).
|
Number of days until the chest drains are removed (usually postoperative day 2 or 3, depending on air leak and amount of fluid).
|
|
Fluid amount
Time Frame: Total amount of fluid at the time of chest drain removal (usually postoperative day 2 or 3, depending on air leak and amount of fluid).
|
Total amount of fluid at the time of chest drain removal (usually postoperative day 2 or 3, depending on air leak and amount of fluid).
|
|
Number of patients with pericardial tamponade that has to be treated by puncture or surgically
Time Frame: Occurrence through hospital stay (an average of 1 week).
|
Occurrence through hospital stay (an average of 1 week).
|
|
Number of patients with pleural effusion at discharge echo, without intervention
Time Frame: Occurrence through hospital stay (an average of 1 week).
|
Occurrence through hospital stay (an average of 1 week).
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Medela1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Air Leak From Lung
-
Baxter Healthcare CorporationCompletedAir Leak From LungItaly, Spain
-
Centre hospitalier de l'Université de Montréal...Recruiting
-
Boston Medical CenterGunze LimitedWithdrawnAir Leak From LungUnited States
-
Lawson Health Research InstituteNot yet recruiting
-
Centre hospitalier de l'Université de Montréal...Recruiting
-
GCS Ramsay Santé pour l'Enseignement et la RechercheRecruiting
-
T.C. Dumlupınar ÜniversitesiBursa Yüksek İhtisas Education and Research HospitalCompletedAir Leak From Lung | Post Procedural Persistent Drain FluidTurkey
-
University Hospital PadovaCompletedLung Cancer Stage I | Lung; Node | Air Leak From LungItaly
-
Lung Healing Technologies IncRecruitingPneumothorax | Air Leak From LungUnited States
-
Wielkopolskie Centrum Pulmonologii i TorakochirurgiiPoznan University of Medical SciencesRecruitingProlonged Air Leak | Persistent Air LeakPoland
Clinical Trials on Pleural drainage system
-
Nova Scotia Health AuthorityCompletedPneumothorax | AtelectasisCanada
-
Peking Union Medical College HospitalNingbo Xinyue Medical Technology Co., LTDRecruiting
-
University Hospital, Clermont-FerrandCompletedPneumothorax | Hemothorax | Pleural EffusionFrance
-
Olav SchjørringRigshospitalet, DenmarkRecruitingRespiratory Failure | Pleural EffusionsDenmark
-
Wuhan YZY Biopharma Co., Ltd.RecruitingA Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLCNSCLC Stage IV | Malignant Pleural EffusionsChina
-
Heidelberg UniversityCompleted
-
Taipei Medical University HospitalNational Science Council, TaiwanUnknown
-
Dokuz Eylul UniversityCompletedUltrasonography | Pleural Effusion | Respiration, Artificial
-
Swedish Medical CenterCompleted
-
Hospices Civils de LyonRecruitingMesothelioma, Malignant | Pleural Mesothelioma | Gene AbnormalityFrance